Tackling vancomycin-resistant bacteria with ‘lipophilic–vancomycin–carbohydrate conjugates’
- 29 October 2014
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 68 (5) , 302-312
Abstract
Vancomycin, a glycopeptide antibiotic, has long been a drug of choice for life-threatening Gram-positive bacterial infections. Vancomycin confers its antibacterial activity by inhibiting bacterial cell wall biosynthesis. However, over the time, vancomycin has also been rendered ineffective by vancomycin-resistant bacteria (VRB). These bacteria developed resistance to it by alteration of cell wall precursor from D-Ala-D-Ala to D-Ala-D-Lac (vancomycin-resistant Enterococci, VRE), which leads to manifold reduction in the binding constant and results in the loss of antibacterial activity. Herein, we report various vancomycin–sugar analogs, based on a simple design rationale, which exhibit increased binding affinity to VRB, thereby resensitizing VRB to vancomycin. Optimized vancomycin–sugar conjugate exhibited 150-fold increase in affinity for N,N′-diacetyl-Lys-D-Ala-D-Lac compared with vancomycin. This improved binding affinity was also reflected in its antibacterial activity, wherein the MIC value was brought down from 750 to 36 μM against VRE (VanA phenotype). To further sensitize against VRE, we appended lipophilic alkyl chain to optimized vancomycin–sugar conjugate. This lipophilic–vancomycin–sugar conjugate was >1000-fold (MIC=0.7 μM) and 250-fold (MIC=1 μM) more effective against VanA and VanB strains of VRE, respectively, compared with vancomycin. Therefore, this synthetically simple approach could lead to the development of new generation of glycopeptide antibiotics, which can be clinically used to tackle VRB infections.Keywords
This publication has 52 references indexed in Scilit:
- Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!Journal of Medicinal Chemistry, 2014
- Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agentsChemical Communications, 2013
- Tackling antibiotic resistanceNature Reviews Microbiology, 2011
- Experimental and Theoretical Studies of the Structures and Interactions of Vancomycin Antibiotics with Cell Wall AnaloguesJournal of the American Chemical Society, 2008
- The Bacteria Fight Back2008
- Glycopeptide and Lipoglycopeptide AntibioticsChemical Reviews, 2005
- Partitioning the Loss in Vancomycin Binding Affinity for d-Ala-d-Lac into Lost H-Bond and Repulsive Lone Pair ContributionsJournal of the American Chemical Society, 2003
- Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistanceThe Lancet Infectious Diseases, 2001
- Managing Antibiotic ResistanceNew England Journal of Medicine, 2000
- Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the storyChemistry & Biology, 1996